Aducanumab aims to help the body clear harmful plaques, or protein clumps, from the brain. Cambridge, Massachusetts-based Biogen is developing it with Japan’s Eisai Co. In afternoon trading, the …
More Experts split sharply over experimental Alzheimer’s drug Videos